We successfully developed PLGA‐PEG NBs targeted CAIX for detecting hypoxia regions within tumors, with small size to penetrate microvessels and arrive at the surface of cells, which was able to detect breast cancer acquired tamoxifen resistance in vitro and in vivo. This evidence concerns the gene CA9 and breast carcinoma.